These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2373 related items for PubMed ID: 28493171

  • 1. Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives.
    Farina MS, Lundgren KT, Bellmunt J.
    Drugs; 2017 Jul; 77(10):1077-1089. PubMed ID: 28493171
    [Abstract] [Full Text] [Related]

  • 2. Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer.
    Katz H, Wassie E, Alsharedi M.
    Med Oncol; 2017 Sep 01; 34(10):170. PubMed ID: 28864844
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Emerging Role of Immunotherapy in Advanced Urothelial Carcinoma.
    Koshkin VS, Grivas P.
    Curr Oncol Rep; 2018 Apr 11; 20(6):48. PubMed ID: 29644490
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. From Clinical Trials to Real-life Clinical Practice: The Role of Immunotherapy with PD-1/PD-L1 Inhibitors in Advanced Urothelial Carcinoma.
    Hussain SA, Birtle A, Crabb S, Huddart R, Small D, Summerhayes M, Jones R, Protheroe A.
    Eur Urol Oncol; 2018 Dec 11; 1(6):486-500. PubMed ID: 31158093
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immune checkpoint inhibitors for metastatic bladder cancer.
    Massari F, Di Nunno V, Cubelli M, Santoni M, Fiorentino M, Montironi R, Cheng L, Lopez-Beltran A, Battelli N, Ardizzoni A.
    Cancer Treat Rev; 2018 Mar 11; 64():11-20. PubMed ID: 29407369
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies.
    Philips GK, Atkins M.
    Int Immunol; 2015 Jan 11; 27(1):39-46. PubMed ID: 25323844
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 119.